John McEnroe is Serious About Getting Men to Take the 50 Over 50 Prostate Health Challenge
- Filed under: Health News
- Date: Mar 17,2009
Three-time Wimbledon and four-time US Open Champion John McEnroe has teamed up with GlaxoSmithKline to create a public-education initiative entitled the “50 Over 50 Prostate Health Challenge.”
Fifty percent of men over 50 years of age have an enlarging prostate; if left untreated it can lead to worsening urinary symptoms and even prostate-related surgery.
“I just celebrated my 50th birthday, and while I’m still as active as ever, I know there are certain health issues I need to stay on top of, including my prostate health,” said McEnroe. “Now I’m asking other men to take the ’50 Over 50 Prostate Health Challenge.’ It’s all about talking to your doctor and getting serious about your prostate health.”
As a part of the campaign, an interactive web site, www.50over50challenge.com, has been created where men can start the “Prostate Health Challenge.” The challenge is to take three easy steps to get serious about prostate health: a brief online prostate health assessment; seeing a doctor for a prostate-health exam; and knowing your PSA (Prostate-specific antigen) level. PSA level, obtained from a simple blood test, is a protein marker that can rise when a prostate condition is present.
McEnroe will also be featured in public education video messages that will appear throughout the year on network television, internet sites and at 50over50challenge.com. The first video vignette will air on April 4 in between the first and second games of the men’s college basketball semi final on CBS. There will also be national print messages in March and April running in such publications as USA Today, Sports Illustrated, Time and Newsweek.
“Prostate health can be awkward to talk about, so we’ve created a series of hopefully memorable, vignettes to help get men talking. I am hoping my involvement will be motivational and encourage men to take the Challenge and take control of their prostate health,” added McEnroe.
Source: GlaxoSmithKline
Leave a comment